"10.1371_journal.pone.0033103","plos one","2012-04-12T00:00:00Z","Gaudensia Mutua; Eduard Sanders; Peter Mugo; Omu Anzala; Jessica E Haberer; David Bangsberg; Burc Barin; James F Rooney; David Mark; Paramesh Chetty; Patricia Fast; Frances H Priddy","Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya; Kenya Medical Research Institute, Kilifi, Kenya; Nuffield Department of Medicine, University of Oxford, Headington, United Kingdom; Massachusetts General Hospital Center for Global Health, Boston, Massachusetts, United States of America; The EMMES Corporation, Rockville, Maryland, United States of America; Gilead, Foster City, California, United States of America; International AIDS Vaccine Initiative, New York, New York, United States of America; International AIDS Vaccine Initiative, Johannesburg, South Africa","Conceived and designed the experiments: FP PF ES GM JFR DB. Performed the experiments: GM ES PM OA PC DM. Analyzed the data: BB FP ES GM JH. Contributed reagents/materials/analysis tools: JFR. Wrote the paper: FP ES GM PM JH DB BB JFR PF.","Burc Barin is employed by a commercial statistical group, The EMMES Corporation. James F. Rooney is employed by a commercial funder of this study, Gilead Sciences, which supplied the active drug and placebo tablets used in this study. Gilead Sciences developed and markets the drug, Truvada, used in this trial for HIV treatment. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Gaudensia Mutua","GM",12,TRUE,6,6,5,9,TRUE,TRUE,FALSE,0,NA,FALSE
